Allergan (AGN) Declares $0.74 Quarterly Dividend; 1.7% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
- Oil prices settle at pre-Iran war levels as crude output grows
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
After-Hours Movers 03/17: (TGE) (HOLX) (AGN) Higher; (MDB) (CHK) (FDX) Lower (more...)
March 17, 2020 5:54 PM EDTAfter-Hours Movers
Tallgrass (NYSE: TGE) 10.1% HIGHER; Blackstone (NYSE: BX) Still Scheduled to Close Tallgrass (NYSE: TGE) Deal With No Material Changes- Bloomberg, Citing DealReporter
AbbVie (ABBV), Allergan (AGN) Sign Consent Decree Agreement with FTC Staff on Pending Transaction
March 17, 2020 4:31 PM EDTAbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, and Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that they have entered into a consent decree agreement with staff of the U.S. Federal Trade Commission... More
